BOLGER JOHN C 4
4 · Fulgent Genetics, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
BOLGER JOHN C
Director
Transactions
- Sale
Common Stock
2022-03-01$61.42/sh−625$38,388→ 2,000 total - Sale
Common Stock
2022-03-01$61.40/sh−625$38,376→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-01−625→ 2,813 totalExercise: $15.82Exp: 2030-05-26→ Common Stock (625 underlying) - Exercise/Conversion
Common Stock
2022-03-01$3.92/sh+625$2,453→ 2,625 total - Sale
Common Stock
2022-03-01$61.27/sh−625$38,293→ 2,000 total - Exercise/Conversion
Common Stock
2022-03-01$5.81/sh+625$3,631→ 2,625 total - Exercise/Conversion
Common Stock
2022-03-01$15.82/sh+625$9,888→ 2,625 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-01−625→ 313 totalExercise: $3.92Exp: 2028-05-18→ Common Stock (625 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-01−625→ 1,563 totalExercise: $5.81Exp: 2029-05-30→ Common Stock (625 underlying)
Footnotes (4)
- [F1]The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F3]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F4]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.